Epicrispr Biotechnologies vs Evozyne
Epicrispr Biotechnologies vs Evozyne, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Evozyne on 55/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 55/100
- domain rating: 40/100 against 31/100
Evozyne
- funding raised: $135M against $90.0M
At a glance
| Measure | Epicrispr Biotechnologies | Evozyne |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | AI-driven biotech company engineering novel proteins for therapeutics and sustainability. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, AI, Drug Discovery, Generative AI |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2020 | 2020 |
| Headquarters | South San Francisco, United States | Chicago, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Evozyne |
|---|---|---|
| Employees | 51 | 54 |
| Total funding | $90.0M | $135M |
| Latest round | Series C | Series B |
| LinkedIn followers | 7,025 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Evozyne |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 55/100 |
| Traction | 57/100 | 57/100 |
| Team | 40/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 20/100 | 9/100 |
| Quality | 78/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 31/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Evozyne |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
Epicrispr Biotechnologies vs Evozyne: common questions
Which is better, Epicrispr Biotechnologies or Evozyne?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Evozyne compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 55/100), domain rating (40/100 against 31/100). Evozyne leads on funding raised ($135M against $90.0M).
Read the full Epicrispr Biotechnologies review and pricing or the Evozyne review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.